vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and OppFi Inc. (OPFI). Click either name above to swap in a different company.
OppFi Inc. is the larger business by last-quarter revenue ($85.6M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). OppFi Inc. runs the higher net margin — 19.7% vs -4.8%, a 24.5% gap on every dollar of revenue. On growth, OppFi Inc. posted the faster year-over-year revenue change (5.9% vs -47.3%). OppFi Inc. produced more free cash flow last quarter ($382.2M vs $74.6M). Over the past eight quarters, OppFi Inc.'s revenue compounded faster (16.3% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
OppFi Inc. is a US-headquartered financial technology firm that provides responsible, accessible financial solutions including installment loans, credit-building tools and related support services to consumers underserved by traditional banking institutions, prioritizing fair terms to help users boost their long-term financial wellness.
IRWD vs OPFI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $85.6M |
| Net Profit | $-2.3M | $16.8M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 36.1% |
| Net Margin | -4.8% | 19.7% |
| Revenue YoY | -47.3% | 5.9% |
| Net Profit YoY | -200.9% | 400.3% |
| EPS (diluted) | $0.01 | $1.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $85.6M | ||
| Q3 25 | $122.1M | $104.6M | ||
| Q2 25 | $85.2M | $100.2M | ||
| Q1 25 | $41.1M | $90.8M | ||
| Q4 24 | $90.5M | $80.8M | ||
| Q3 24 | $91.6M | $91.2M | ||
| Q2 24 | $94.4M | $86.3M | ||
| Q1 24 | $74.9M | $63.2M |
| Q4 25 | $-2.3M | $16.8M | ||
| Q3 25 | $40.1M | $41.6M | ||
| Q2 25 | $23.6M | $-20.8M | ||
| Q1 25 | $-37.4M | $-11.4M | ||
| Q4 24 | $2.3M | $-5.6M | ||
| Q3 24 | $3.6M | $4.3M | ||
| Q2 24 | $-860.0K | $3.1M | ||
| Q1 24 | $-4.2M | $5.5M |
| Q4 25 | 14.3% | 36.1% | ||
| Q3 25 | 61.8% | 46.3% | ||
| Q2 25 | 53.2% | 44.7% | ||
| Q1 25 | -70.7% | 46.8% | ||
| Q4 24 | 34.8% | 30.5% | ||
| Q3 24 | 28.0% | 38.5% | ||
| Q2 24 | 26.5% | 34.2% | ||
| Q1 24 | 14.7% | 8.4% |
| Q4 25 | -4.8% | 19.7% | ||
| Q3 25 | 32.8% | 39.8% | ||
| Q2 25 | 27.7% | -20.7% | ||
| Q1 25 | -90.9% | -12.5% | ||
| Q4 24 | 2.5% | -6.9% | ||
| Q3 24 | 4.0% | 4.7% | ||
| Q2 24 | -0.9% | 3.6% | ||
| Q1 24 | -5.6% | 8.8% |
| Q4 25 | $0.01 | $1.48 | ||
| Q3 25 | $0.23 | $0.77 | ||
| Q2 25 | $0.14 | $-0.78 | ||
| Q1 25 | $-0.23 | $-0.48 | ||
| Q4 24 | $0.03 | $-0.11 | ||
| Q3 24 | $0.02 | $0.21 | ||
| Q2 24 | $-0.01 | $0.16 | ||
| Q1 24 | $-0.03 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $49.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $58.5M |
| Total Assets | $396.9M | $754.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $49.5M | ||
| Q3 25 | $140.4M | $45.5M | ||
| Q2 25 | $92.9M | $45.2M | ||
| Q1 25 | $108.5M | $58.0M | ||
| Q4 24 | $88.6M | $61.3M | ||
| Q3 24 | $88.2M | $44.8M | ||
| Q2 24 | $105.5M | $46.6M | ||
| Q1 24 | $121.5M | $47.2M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $58.5M | ||
| Q3 25 | $-264.2M | $49.4M | ||
| Q2 25 | $-308.2M | $13.4M | ||
| Q1 25 | $-334.1M | $22.6M | ||
| Q4 24 | $-301.3M | $32.8M | ||
| Q3 24 | $-311.3M | $34.9M | ||
| Q2 24 | $-321.7M | $18.6M | ||
| Q1 24 | $-330.5M | $18.2M |
| Q4 25 | $396.9M | $754.1M | ||
| Q3 25 | $396.1M | $720.6M | ||
| Q2 25 | $342.9M | $673.4M | ||
| Q1 25 | $327.2M | $640.1M | ||
| Q4 24 | $350.9M | $641.2M | ||
| Q3 24 | $389.5M | $619.3M | ||
| Q2 24 | $395.6M | $573.1M | ||
| Q1 24 | $438.8M | $563.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $401.3M |
| Free Cash FlowOCF − Capex | $74.6M | $382.2M |
| FCF MarginFCF / Revenue | 156.3% | 446.6% |
| Capex IntensityCapex / Revenue | 0.0% | 22.3% |
| Cash ConversionOCF / Net Profit | — | 23.82× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $652.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $401.3M | ||
| Q3 25 | $47.6M | $105.1M | ||
| Q2 25 | $-15.1M | $95.6M | ||
| Q1 25 | $20.0M | $83.7M | ||
| Q4 24 | $15.2M | $323.8M | ||
| Q3 24 | $9.9M | $77.6M | ||
| Q2 24 | $33.5M | $77.3M | ||
| Q1 24 | $45.0M | $74.4M |
| Q4 25 | $74.6M | $382.2M | ||
| Q3 25 | $47.6M | $99.9M | ||
| Q2 25 | $-15.1M | $91.0M | ||
| Q1 25 | $19.9M | $79.3M | ||
| Q4 24 | — | $310.8M | ||
| Q3 24 | $9.9M | $73.7M | ||
| Q2 24 | $33.4M | $74.7M | ||
| Q1 24 | $44.9M | $72.3M |
| Q4 25 | 156.3% | 446.6% | ||
| Q3 25 | 39.0% | 95.6% | ||
| Q2 25 | -17.7% | 90.8% | ||
| Q1 25 | 48.4% | 87.4% | ||
| Q4 24 | — | 384.6% | ||
| Q3 24 | 10.8% | 80.8% | ||
| Q2 24 | 35.4% | 86.6% | ||
| Q1 24 | 60.0% | 114.4% |
| Q4 25 | 0.0% | 22.3% | ||
| Q3 25 | 0.0% | 5.0% | ||
| Q2 25 | 0.0% | 4.6% | ||
| Q1 25 | 0.1% | 4.8% | ||
| Q4 24 | 0.0% | 16.1% | ||
| Q3 24 | 0.0% | 4.3% | ||
| Q2 24 | 0.1% | 3.0% | ||
| Q1 24 | 0.1% | 3.4% |
| Q4 25 | — | 23.82× | ||
| Q3 25 | 1.19× | 2.52× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 18.19× | ||
| Q2 24 | — | 25.21× | ||
| Q1 24 | — | 13.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
